Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1,262
Index Copernicus (ICV) – 155,19; MNiSW – 15
Ogólny współczynnik odrzuceń – 84,38%
ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodyczność – miesięcznik

Pobierz PDF

Advances in Clinical and Experimental Medicine

2018, tom 27, nr 2, luty, str. 207–216

doi: 10.17219/acem/66354

Typ publikacji: praca oryginalna

Język publikacji: angielski

Pobierz cytowania:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

The effect of high intensity physical exercise and hypoxia on glycemia, angiogenic biomarkers and cardiorespiratory function in patients with type 1 diabetes

Aleksandra Żebrowska1,A,B,C,D,F, Barbara Hall1,B,C, Aleksandra Kochańska-Dziurowicz2,B, Grażyna Janikowska3,E

1 Department of Physiological and Medical Sciences, Academy of Physical Education, Katowice, Poland

2 Department of Health Care, Silesian Medical College, Katowice, Poland

3 Department of Analytical Chemistry, Medical University of Silesia, Katowice, Poland

Abstract

Background. An integral part of the treatment of diabetes is physical activity. Scientific reports have shown the beneficial effects of hypoxia and exercise on cardiovascular and metabolic variables in patients with diabetes.
Objectives. The aim of the study was to assess the effect of normobaric hypoxia and exercise on the serum concentrations of proangiogenic factors and glycemia in patients with type 1 diabetes.
Material and Methods. A total of 28 adults (aged 30.4 years ±9.7 years), suffering from diabetes for 12.1 years ±6.0 years and healthy individuals, participated in the following trials: normoxic (Nor) and hypoxic (Hy) rest and Nor and Hy incremental exercise test (Ex) (FIO2 = 15.2%). The Altitude Trainer Hypoxico System (HYP-123 Hypoxic Generator, LOWOXYGEN Technology GmbH, Berlin, Germany) corresponding to a height of about 2500 m above sea level was used in the study. Exercise tests were performed on a cycle ergometer Excalibur Sport (Lode B.V., Groningen, The Netherlands). Cardiorespiratory variables, glycemia, angiogenic and hematological indices were measured at rest and in response to both exercise protocols.
Results. The present data confirmed that the patients with type 1 diabetes demonstrated a good level of aerobic capacity and fitness. NorEx and HyEx resulted in a significant decrease in serum glucose concentration (p < 0.05 vs p < 0.01). Patients with diabetes had higher baseline hypoxia induced factor-1alpha levels compared to healthy adults (p < 0.05), which increased after exposure to hypoxia and hypoxia with exercise (p < 0.001). Hypoxia significantly decreased baseline transforming growth factor-β (TGF-β) (p < 0.05) and had a significant effect on tumor necrosis factor-α level (TNF-α) (F = 4.9; p < 0.05).
Conclusion. Our study demonstrated that hypoxia combined with exercise reduces glycemia and may induce significant benefits in the prevention of diabetes cardiovascular complications.

Key words

angiogenesis, type 1 diabetes mellitus, exercise tolerance, hypoxia-inducible factor-1

Piśmiennictwo (33)

  1. American Diabetes Association. Standards of medical care in diabetes – 2010: Current criteria for the diagnosis of diabetes. Diabetes Care. 2010;33(1):4–10.
  2. Hayes Ch, Kriska A. Role of physical activity in diabetes management and prevention. J Am Diet Assoc. 2008;108(1):19–23. doi:10.1016/j.jada.2008.01.016
  3. Carral F, Gutiérrez JV, Ayala MD, García G, Aguilar M. Intense physical activity is associated with better metabolic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2013;101(1):45–49. doi:10. 1016/j.diabres.2013.04.006
  4. American Diabetes Association. Standards of medical care in diabetes – 2015. Diabetes Care. 2015;38(1):10–38.
  5. Pavan P, Sarto P, Merlo L, et al. Metabolic and cardiovascular parameters in type 1 diabetes at extreme altitude. Med Sci Sports Exerc. 2004;36(8):1283–1289.
  6. Kalson NS, Davies AJ, Stokes S, et al. Climbers with diabetes do well on Mount Kilimanjaro. Diabet Med. 2007;24(12):1496.
  7. Lehnen AM, Angelis KD, Markoski MM, Schaan BDA. Changes in the GLUT4 expression by acute exercise, exercise training and detraining in experimental models. J Diabetes Metab. 2012;10:002. doi:10. 4172/2155–6156
  8. D’hooge R, Hellinckx T, Calders P. Influence of combined aerobic and resistance training on metabolic control, cardiovascular fitness and quality of life in adolescents with type 1 diabetes: A randomized controlled trial. Clin Rehabil. 2011;25(4):349–359. doi:10.1177/ 0269215510386254
  9. Jensen L, Bangsbo J, Hellsten Y. Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle. J Physiol. 2004;557:571–582.
  10. Schobersberger W, Schmid P, Lechleitner M, et al. Austrian Moderate Altitude Study 2000 (AMAS). The effects of moderate altitude (1,700 m) on cardiovascular and metabolic variables in patients with metabolic syndrome. Eur J Appl Physiol. 2003;88:506–514.
  11. Silvestre JS, Lévy BI. Molecular basis of angiopathy in diabetes mellitus. Circ Res. 2006;98:4–6.
  12. Di Marzio D, Mohn A, Mokini Z, Giannini C, Chiarelli F. Macroangiopathy in adults and children with diabetes: From molecular mechanisms to vascular damage (part 1). Hormone Metab Res. 2006;38(11):691–705.
  13. Chiarelli F, Spagnoli A, Basciani F, et al. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: Relation to glycaemia control and microvascular complications. Diabetic Med. 2000;17(9):650–656.
  14. Wee J, Climstein M. Hypoxic training: Clinical benefits on cardiometabolic risk factors. J Sci Med Sport. 2015;18(1):56–61. doi:10.1016/j.jsams.2013.10.247
  15. Mackenzie R, Maxwell N, Castle P, Brickley G, Watt P. Acute hypoxia and exercise improve insulin sensitivity (S(I) (2*) in individuals with type 2 diabetes. Diabetes/Metab Res Rev. 2011;27(1):94–101. doi:10. 1002/dmrr.1156
  16. Kivelä R, Silvennoinen M, Touvra AM, Lehti TM, Kainulainen H, Vihko V. Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J. 2006;20(9):1570–1572.
  17. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev. 2003;23(2):117–145.
  18. Mackenzie R, Elliott B, Maxwell N, Brickley G, Watt P. The effect of hypoxia and work intensity on insulin resistance in type 2 diabetes. J Clin Endocrinol Metab. 2012;97(1):155–162. doi:10.1210/jc.2011–1843
  19. Thangarajah H, Vial IN, Grogan RH, et al. HIF-1alpha dysfunction in diabetes. Cell Cycle. 2010;9(1):75–79.
  20. Thangarajah H, Yao D, Chang EI, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA. 2009:106(32):13505–13510. doi:10.1073/pnas.0906670106
  21. Azevedo JL Jr, Carey JO, Pories WJ, Morris PG, Dohm GL. Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes. 1995;44(6):695–698.
  22. Chen CH, Liu YF, Lee SD, et al. Altitude hypoxia increases glucose uptake in human heart. High Alt Med Biol. 2009;10:83–86. doi:10.1089/ham.2008.1064
  23. Mackenzie R, Maxwell N, Castle P, Elliott B, Brickley G, Watt P. Intermittent exercise with and without hypoxia improves insulin sensitivity in individuals with type 2 diabetes. J Clin Endocrinol Metab. 2012;97(4):546–555. doi:10.1210/jc.2011–2829
  24. Castillo O, Woolcott OO, Gonzales E, et al. Residents at high altitude show a lower glucose profile than sea-level residents throughout 12-hour blood continuous monitoring. High Alt Med Biol. 2007;8: 307–311.
  25. Lundby C, Calbet JAL, Robach P. The response of human skeletal muscle tissue to hypoxia. Cell Mol Life Sci. 2009;66:3615–3623. doi:10.1007/s00018-009-0146-8
  26. Millet GP, Roels B, Schmitt L, Woorons X, Richalet JP. Combining hypoxic methods for peak performance. Sports Med. 2010;40(1):1–25.
  27. Sánchez-Elsner T, Botella LM, Velasco B, Corbí A, Attisano L, Bernabéu C. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem. 2001;276(42):38527–38535.
  28. Shaker YM, Hanan A, Soliman HA, et al. Serum and urinary transforming growth factor beta 1 as biochemical markers in diabetic nephropathy patients. Beni-Suef Univ J Basic Appl Sci. 2014;3(1):16–23.
  29. Cabrera SM, Rigby MR, Mirmira RG. Targeting regulatory T cells in the treatment of type 1 diabetes mellitus. Curr Mol Med. 2012:12(10); 1261–1272.
  30. Chen W, Salojin KV, Mi QS, Meagher TC, Zucker P, Delovitch TL. Insulin-like growth factor (IGF)-I/IGF-binding protein 3 complex: Therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology. 2004;145:627–638.
  31. Simons M. Angiogenesis, arteriogenesis, and diabetes: Paradigm reassessed? J Am Coll Cardiol. 2005;46:835–837.
  32. Xiao H, Gu Z, Wang G, Zhao T. The possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapies. Int J Med Sci. 2013;10(10):1414–1421. doi:10.7150/ijms.5630
  33. Kuehl MN, Rodriguez H, Burkhard BR, Alman AC. Tumor necrosis factor-α, matrix-metalloproteinases 8 and 9 levels in the saliva are associated with increased hemoglobin a1c in type 1 diabetes subjects. PLoS One. 2015;10(4):e0125320. doi:10.1371/journal.pone. 0125320